Cargando…
The I2020T Leucine-rich repeat kinase 2 transgenic mouse exhibits impaired locomotive ability accompanied by dopaminergic neuron abnormalities
BACKGROUND: Leucine-rich repeat kinase 2 (LRRK2) is the gene responsible for autosomal-dominant Parkinson’s disease (PD), PARK8, but the mechanism by which LRRK2 mutations cause neuronal dysfunction remains unknown. In the present study, we investigated for the first time a transgenic (TG) mouse str...
Autores principales: | Maekawa, Tatsunori, Mori, Sayuri, Sasaki, Yui, Miyajima, Takashi, Azuma, Sadahiro, Ohta, Etsuro, Obata, Fumiya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3467184/ https://www.ncbi.nlm.nih.gov/pubmed/22534020 http://dx.doi.org/10.1186/1750-1326-7-15 |
Ejemplares similares
-
Leucine-rich repeat kinase 2 (LRRK2) regulates α-synuclein clearance in microglia
por: Maekawa, Tatsunori, et al.
Publicado: (2016) -
Leucine-Rich Repeat Kinase 2 Controls Inflammatory Cytokines Production through NF-κB Phosphorylation and Antigen Presentation in Bone Marrow-Derived Dendritic Cells
por: Kubo, Makoto, et al.
Publicado: (2020) -
LRRK2 Phosphorylates Tubulin-Associated Tau but Not the Free Molecule: LRRK2-Mediated Regulation of the Tau-Tubulin Association and Neurite Outgrowth
por: Kawakami, Fumitaka, et al.
Publicado: (2012) -
Dopaminergic regulation of muscle tone and locomotion : an experimental study in the rat /
por: Johnels, Bo
Publicado: (1981) -
Rapid signaling in distinct dopaminergic axons during locomotion and reward
por: Howe, MW, et al.
Publicado: (2016)